Cyclin-Dependent Kinase 6 Identified as the Target Protein in the Antitumor Activity of Tetrastigma hemsleyanum

BACKGROUND: Tetrastigma hemsleyanum (T. hemsleyanum) is widely used as an adjuvant drug for tumor therapy but its antitumor therapeutic targets and molecular mechanisms have remained unclear. The prediction and analysis of natural products has previously used only network pharmacology methods to ide...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Chaoguang, Zhao, Yuxiang, Ji, Tao, Sun, Yong, Cai, Xudong, Peng, Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9035993/
https://www.ncbi.nlm.nih.gov/pubmed/35480115
http://dx.doi.org/10.3389/fonc.2022.865409

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9035993/
https://www.ncbi.nlm.nih.gov/pubmed/35480115
http://dx.doi.org/10.3389/fonc.2022.865409

Ejemplares similares